- Histoplasma capsulatum causes histoplasmosis — one of the most common fungal infections in the United States, with an estimated 500,000 new cases per year, most of which go undiagnosed.
- The fungus is environmentally associated with soil enriched by bat and bird (particularly starling and blackbird) droppings; endemic areas in the U.S. center on the Ohio and Mississippi River valleys.
- Most infections in healthy individuals are asymptomatic or self-limiting; severe disease occurs primarily in immunocompromised individuals or following high-dose exposure.
- Disturbance of contaminated soil or structures (demolition, excavation, cave exploration, clearing bird roosts) can cause point-source outbreaks affecting large numbers of people simultaneously.
- H. capsulatum is a dimorphic fungus — growing as a mold in the environment and converting to yeast form at human body temperature (37°C), a switch essential for its pathogenicity.
Histoplasma capsulatum is among the most epidemiologically significant endemic mycoses in the Americas. Unlike opportunistic molds such as Aspergillus that primarily threaten immunocompromised patients, Histoplasma regularly infects otherwise healthy individuals in endemic regions — and the vast majority of cases go unrecognized because they resemble mild influenza or cause no symptoms at all. This profile covers the organism’s biology, geographic distribution, clinical presentations, and what determines whether infection becomes serious.
Taxonomy and Classification
Histoplasma capsulatum Darling belongs to the family Ajellomycetaceae, order Onygenales, class Eurotiomycetes. Three varieties have been historically recognized: var. capsulatum (the predominant form in the Americas and worldwide), var. duboisii (African histoplasmosis, causing larger tissue lesions with distinct histopathology), and var. farciminosum (equine histoplasmosis). Molecular phylogenetic analysis has revealed that the global population of H. capsulatum constitutes eight or more cryptic phylogenetic species — organisms that appear identical morphologically but are genetically distinct — though the clinical significance of these genetic divisions is still being characterized.
Dimorphism: The Environmental-to-Pathogenic Switch
Histoplasma capsulatum is a thermally dimorphic fungus — one of approximately 6 major human pathogens with this critical biological property:
- At environmental temperatures (below 30°C): Grows as a mold (mycelial phase), producing two types of conidia — large, thick-walled tuberculate macroconidia (8–16 μm, with characteristic spiny surface projections) and small, smooth microconidia (2–5 μm). The microconidia are the primary infectious propagules due to their small size, which enables deep lung deposition.
- At mammalian body temperature (37°C): Converts to a small (2–4 μm), oval yeast-phase cell that replicates within macrophages. This intramacrophagic survival — the ability to live and replicate within the very immune cells sent to destroy it — is the central pathogenic strategy.
Geographic Distribution and Environmental Sources
H. capsulatum is distributed globally but highly concentrated in specific geographic niches. The organism grows in soil enriched with nitrogen from animal excreta, particularly bat guano and bird (starling, blackbird, chicken) droppings. In the United States, the hyperendemic zone encompasses the Ohio, Missouri, and Mississippi River valleys, including the states of Ohio, Indiana, Kentucky, Tennessee, Missouri, Illinois, and Arkansas. Seroprevalence surveys from the 1940s–1960s indicated that 80% or more of adults in some Ohio River valley cities had evidence of prior Histoplasma infection. Internationally, endemic zones include Central and South America, parts of Africa, Asia, and Australia.
Specific high-risk environmental sources include: bat-inhabited caves, hollow trees, and attics; areas beneath large bird roosts; chicken coops and other poultry facilities; and disturbed soil or structures in endemic areas.
Clinical Presentations
The clinical outcome of H. capsulatum infection is determined by inoculum dose and host immune status:
- Asymptomatic infection: The majority of infections in healthy individuals — estimated 90% or more of infections in endemic regions — cause no symptoms or symptoms so mild they go unattributed to any specific illness.
- Acute pulmonary histoplasmosis: Following moderate or high inoculum exposure, flu-like illness develops 3–17 days after exposure, with fever, chills, headache, myalgia, and a nonproductive cough. Most cases resolve spontaneously within 2–4 weeks. Chest radiography may show patchy infiltrates and hilar lymphadenopathy — findings that can mimic tuberculosis or sarcoidosis.
- Progressive disseminated histoplasmosis: In immunocompromised patients (HIV/AIDS with CD4 count below 150 cells/μL, transplant recipients, those on high-dose corticosteroids or TNF-alpha inhibitors), infection can disseminate from the lungs to involve the liver, spleen, bone marrow, and adrenal glands. Without treatment, mortality exceeds 80%; with itraconazole or amphotericin B treatment, outcomes are substantially improved.
- Chronic cavitary histoplasmosis: In patients with pre-existing structural lung disease (COPD, emphysema), Histoplasma can cause chronic cavitary pneumonia resembling tuberculosis.
Diagnosis and Treatment
Histoplasmosis is frequently misdiagnosed as bacterial pneumonia, tuberculosis, or sarcoidosis. Urinary Histoplasma antigen detection (enzyme immunoassay) is the most sensitive diagnostic test for disseminated and acute severe disease. Treatment for mild-moderate disease is itraconazole; severe or disseminated disease requires liposomal amphotericin B followed by itraconazole maintenance.
Frequently Asked Questions
Where is histoplasmosis most common in the United States?
Histoplasmosis is most common in the Ohio and Mississippi River valleys, including Ohio, Indiana, Kentucky, Tennessee, Missouri, Illinois, and Arkansas. Historical skin test surveys found that 80% or more of adult residents of some Ohio River valley cities had evidence of prior Histoplasma exposure. It also occurs in the mid-Atlantic states, parts of the South, and Latin America. Cases outside endemic regions are usually in travelers returning from endemic areas.
Can you get histoplasmosis without a bat cave?
Yes. While bat caves are a classic exposure site, Histoplasma also grows in bird roosts (particularly European starling congregations under bridges and in urban trees), chicken coops, soil around old buildings in endemic areas, and disturbed ground in construction or landscaping projects. Point-source outbreaks have occurred in schools, construction sites, and neighborhoods where old trees with bird roost history were felled.
Is histoplasmosis contagious?
No. Histoplasmosis is not transmitted from person to person. Infection occurs exclusively by inhaling Histoplasma conidia from environmental sources. The yeast form that exists in human tissue is not infectious to others. This means that a person with active histoplasmosis poses no infection risk to household contacts, healthcare workers, or visitors.
Why does histoplasmosis often go undiagnosed?
Most Histoplasma infections in healthy individuals cause no symptoms or produce a mild flu-like illness that resolves spontaneously — patients never seek care, or the illness is attributed to viral respiratory infection. When symptomatic cases do present to healthcare providers outside endemic regions (or to providers unfamiliar with the diagnosis), histoplasmosis is frequently mistaken for community-acquired bacterial pneumonia, tuberculosis, sarcoidosis, or lymphoma, particularly when imaging shows hilar lymphadenopathy.
How is histoplasmosis prevented?
Prevention focuses on reducing exposure to contaminated dust. In high-risk activities (demolishing old buildings in endemic areas, cleaning bat or bird roosts, excavating soil in endemic zones), use of an N95 respirator or powered air-purifying respirator (PAPR) is recommended. Wetting contaminated soil before disturbance reduces dust generation. Immunocompromised individuals in endemic areas should avoid activities with high exposure risk. No vaccine is available.
